Breast cancer is one of the most well-known and widespread forms of cancer in the
United States today with over 40,000 deaths being attributed to it annually. According to the
American Cancer Society, over 90% of these deaths are due to the cancer spreading to other
areas of the body.1
Previous studies have shown that this aggressive action by the cancer is due
to specific types of breast cancer cells that are also known to be resistant to conventional
In this project, I elucidate a new potential drug target found in these cells. If drugs
against this target come into use in the clinic, it may result in prevention of breast cancer
spreading and increased long term survival for patients.
The file is restricted for YU community access only.